Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 10,428 shares at $58.39 ($611K) on 2025-02-10, disclosed to the SEC on 2025-02-11.
Scheduled sale ($611k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.39 | 1,894 | $111K | 18.1% |
| 2 | $58.39 | 1,894 | $111K | 18.1% |
| 3 | $59.34 | 2,295 | $136K | 22.3% |
| 4 | $59.34 | 2,295 | $136K | 22.3% |
| 5 | $57.50 | 4 | $230 | 0.0% |
| 6 | $57.51 | 1,023 |
| $59K |
| 9.6% |
| 7 | $57.51 | 1,023 | $59K | 9.6% |
| Total | $58.64 avg | 10,428 | $611K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |
| RYTM | SELL | 2025-02-04 | $172K | — | Filing → |